USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Clinical Chemistry and Immunoassay Industry, Global, 2023?2028
Integrated and Scalable Core Lab Solutions Driving Transformational Growth
30-Oct-2024
Global
Market Research
PFPY-01-00-00-00
HC_2024_1106
This analysis examines the global clinical chemistry and immunoassay sector, accounting for the highest share in the in vitro diagnostics (IVD) market. This type of lab-based testing analyzes body fluids (usually blood, urine, or saliva) using integrated/standalone analyzers and a wide range of assays/panels, among other solutions and services to support the diagnosis and treatment of human health.
While clinical chemistry instruments and tests target different chemicals in body fluids to evaluate health and the clinical management of patients, immunoassay instruments and tests measure the presence or concentration of analytes in biological liquid by using the binding of antibodies to antigens to identify and measure certain substances. This competitive analysis examines IVD companies that provide a broad menu of clinical chemistry and immunoassay systems, including instruments and consumables. Key end-user verticals comprise hospitals, clinics, diagnostic laboratories, and research institutions. The sector is segmented by applications, including cancer/oncology, cardiac, diabetes, infectious, and others, for market revenue estimations and forecasts. The study also identifies four growth opportunities that build on trends, maximize the economic potential, and sustain value.
Author: Amartya Bose
Scope of Analysis
Segmentation
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Clinical Chemistry and Immunoassay Industry
Competitive Environment
Key Competitors
Growth Metrics
Growth Drivers
Growth Drivers (continued)
Growth Restraints
Forecast Considerations
Revenue Forecast
Revenue Forecast by Application Areas
Revenue Forecast by Region
Revenue Forecast Analysis
Pricing Trends and Forecast Analysis
Revenue Share
Revenue Share Analysis
Revenue Share Analysis (continued)
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Growth Opportunity 1: Sepsis IVDs
Growth Opportunity 1: Sepsis IVDs (continued)
Growth Opportunity 2: Neurology IVDs
Growth Opportunity 2: Neurology IVDs (continued)
Growth Opportunity 3: Routine Testing
Growth Opportunity 3: Routine Testing (continued)
Growth Opportunity 4: Integrated Analyzers
Growth Opportunity 4: Integrated Analyzers (continued)
Benefits and Impacts of Growth Opportunities
Next Steps
List of Exhibits
List of Exhibits (continued)
Legal Disclaimer
List of Figures
- Clinical Chemistry and Immunoassay: Growth Metrics, Global, 2023‒2028
- Clinical Chemistry and Immunoassay: Growth Drivers, Global, 2024-2028
- Clinical Chemistry and Immunoassay: Growth Restraints, Global, 2024-2028
- Clinical Chemistry and Immunoassay: Revenue Forecast, Global, 2023‒2028
- Clinical Chemistry and Immunoassay: Revenue Forecast by Application Areas, Global, 2023-2028
- Clinical Chemistry and Immunoassay: Revenue Forecast by Region, 2023-2028
- Clinical Chemistry and Immunoassay: Revenue Share of Top Participants, Global, 2023
- Cancer: Growth Metrics, Global, 2023
- Cancer: Revenue Forecast, Global, 2023-2028
- Cancer: Revenue Forecast by Region, 2023-2028
- Cardiac: Growth Metrics, Global, 2023
- Cardiac: Revenue Forecast, Global, 2023-2028
- Cardiac: Revenue Forecast by Region, 2023-2028
- Diabetes: Growth Metrics, Global, 2023
- Diabetes: Revenue Forecast, Global, 2023-2028
- Diabetes: Revenue Forecast by Region, 2023-2028
- Infectious Diseases: Growth Metrics, Global, 2023-2028
- Infectious Diseases: Revenue Forecast, Global, 2023-2028
- Infectious Diseases: Revenue Forecast by Region, 2023-2028
- Others: Growth Metrics, Global, 2023-2028
- Others: Revenue Forecast, Global, 2023-2028
- Others: Revenue Forecast by Region, 2023-2028
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
28 Oct 2026 | Global | Frost Radar
Frost Radar™: Health Monitoring Wearable Solutions, 2026
The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...
26 Oct 2026 | Global | Technology Research
Game-Changing Innovations Transforming Cardiovascular Care
The study analyzes game-changing technologies transforming cardiovascular care across diagnosis, image-guided intervention, functional assessment, clinical workflow, and longitudinal patient monitoring. The analysis covers five segments: diagnostic imaging and AI-enabled cardiac assessment; interve...
23 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Implantable and Diagnostic Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantable.The issue features advanced medical devices such as single-breath-hold radiotherapy system, transcatheter system f...
16 Oct 2026 | Global | Market Research
Public Sector Healthcare Cloud Market, North America and Europe, 2026
Public healthcare organizations across North America and Europe are using cloud technologies to support modernization efforts that extend beyond infrastructure replacement. Cloud is increasingly being adopted to improve interoperability, enable secure data sharing, support analytics and AI initiativ...
16 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Precision Therapeutics, AI-Enabled Discovery and Bioengineering, Regenerative Medicine, and Next-Generation Vaccine Platforms
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming precision therapeutics, regenerative medicine, AI-enabled discovery, laboratory automation, targeted delivery, vaccines, and biomanufactu...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.